Antimicrobial activity of new anti-Pseudomonas beta-lactam-beta-lactamase inhibitors against Pseudomonas aeruginosa respiratory isolates recovered during the study for Monitoring Antimicrobial Resistance Trends (SMART) program in France (2016–2022)

Authors:

Abstract
No abstract available
Funding Information
  • Merck Sharp and Dohme France

This publication has 24 references indexed in Scilit: